Biotech · Private company · Worcester, MA, US
Microbiotix, Inc
Track this companyFree. Adds Microbiotix, Inc to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards10
- Translational studies to advance Filociclovir to IND submission for the treatment of adenoviral conjunctivitis and acute keratoconjunctivitisFiscal year 2026 · $669.9KNIH RePORTER 5R33EY036947-02 · fetched Nov 12, 2026
- Novel Benzyl-Piperidine antifungal agents to treat intractable Mucorales infectionsFiscal year 2026 · $299.4KNIH RePORTER 5R41AI195240-02 · fetched Nov 12, 2026
- Discovery of Bunyaviral Endonuclease Inhibitors for Anti ViralFiscal year 2026 · $969.1KNIH RePORTER 5R42AI165102-04 · fetched Nov 12, 2026
- Development of well tolerated novel Inhibitors of drug resistant CMVFiscal year 2026 · $289.3KNIH RePORTER 5R43AI188690-02 · fetched Nov 12, 2026
- DEVELOPMENT OF PAN-FILOVIRUS THERAPEUTICSFiscal year 2026 · $3.8MNIH RePORTER 75N93023C00001-P00005-9999-1 · fetched Nov 12, 2026
- Translational studies to advance Filociclovir to IND submission for the treatment of adenoviral conjunctivitis and acute keratoconjunctivitisFiscal year 2025 · $675KNIH RePORTER 1R33EY036947-01 · fetched Nov 12, 2026
- Novel Benzyl-Piperidine antifungal agents to treat intractable Mucorales infectionsFiscal year 2025 · $299.9KNIH RePORTER 1R41AI195240-01 · fetched Nov 12, 2026
- Development of well tolerated novel Inhibitors of drug resistant CMVFiscal year 2025 · $298.6KNIH RePORTER 1R43AI188690-01A1 · fetched Nov 12, 2026
- Discovery of Bunyaviral Endonuclease Inhibitors for Anti ViralFiscal year 2025 · $977.4KNIH RePORTER 2R42AI165102-03 · fetched Nov 12, 2026
- Proof of concept experiments for T3SS inhibitors against burn wound infectionsFiscal year 2025 · $300KNIH RePORTER 5R41AI183900-02 · fetched Nov 12, 2026